QuickView for PDCD1LG2;jsessionid=3FCD09B52ED3AB2E8B20F2490CC606FF (gene)

1. Pan-cancer analysis identifies PD-L2 as a tumor promotor in the tumor microenvironment.
2. Targeting PD-L2-RGMb overcomes microbiome-related immunotherapy resistance.
3. PD-L1 and PD-L2 expression in colorectal cancer.
4. Expression of Programmed Cell Death 1 Ligand 2 in Patients With Thymoma and Thymomatous Myasthenia G…
5. PD-L1 and PD-L2 Mutations in Pediatric Hodgkin Lymphoma: Do They Have Any Prognostic Significance?

There were no clinical trials for PDCD1LG2;jsessionid=3FCD09B52ED3AB2E8B20F2490CC606FF